BOARD MEMBERS​

BOARD MEMBERS

Anke Van Dam

Anke is an experienced skilled manager working in following domains: Non-profit, Non-Governmental Organizations, sustainable development, change management and strategic development.

She is also an implementer of multi-country projects with an interest in Universal Health Coverage. Where she ensures equal access to health for everyone, including the underserved groups in society, with a specific expertise in Sexual and Reproductive Health and Rights including HIV and community based participatory research.

Also is she a strong business development professional, graduated from RSM Erasmus University.

Mikhail Golichenko

Mikhail Golichenko is a long-term advocate for legal reform and human rights based public health in EECA. He is a senior policy analyst at the Canadian HIV/AIDS Legal Network where he leads the research and advocacy work in Russian-speaking countries, with a particular focus on drug policy issues. He has authored several publications on civil litigation issues in Russia.

Previously, Mikhail was a Legal Officer with the UNODC Country Office for the Russian Federation in Moscow, where his work focused on the promotion of human rights and addressing legal barriers to effective HIV/AIDS prevention
and care programs for prisoners and people who inject drugs.

He has also worked for the UN Peacekeeping in West Africa and the Russian police service. Mikhail holds a Candidate of Sciences degree (PhD equivalent) in Russian Civil Law from Saratov State Academy of Law and an LL.M. in Canadian Common Law from Osgoode Hall Law School of York University. He has been a member of the Russian Bar Association since 2007.

Jean-Paul Grund

Jean-Paul Grund has published extensively on drug culture, the diffusion of drug trends, HIV and other drug related morbidity, drug policy, peer-driven harm reduction approaches and the self-regulation of psychoactive substance use. His current interests include homemade drugs (e.g. Russian “Krokodil,” Czech “Pervitin”), new psychoactive substances (NPS or “legal highs”), online drug commerce and the influence of technology on drug markets, consumption and policy. He is project leader and research coordinator of multiple projects on drug use in both recreational consumers and vulnerable populations.

As the founding director of the International Harm Reduction Development program of the Open Society Institute and as Technical Advisor at UNAIDS, he worked with NGO’s, state agencies and policy makers on developing the first HIV prevention and harm reduction responses to the syndemic of drug injecting, infectious diseases and social upheaval in Central Europe, Russia and the Newly Independent States.

Scroll to top